Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Investigation|April 1, 1973
Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patientsR E Rangno, J S Kaufmann, J H Cavanaugh, et al.Journal of Clinical Pharmacology|August 1, 1993
Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobialS Chu, D S Wilson, R L Deaton, et al.Clinical Pharmacokinetics|January 1, 1995
Pharmacokinetic interactions between zileuton and prednisoneW M Awni, J H Cavanaugh, T B Tzeng, et al.Clinical Pharmacokinetics|January 1, 1995
Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humansW M Awni, Z Hussein, G R Granneman, et al.Clinical Pharmacokinetics|January 1, 1995
Effect of zileuton on theophylline pharmacokineticsG R Granneman, R A Braeckman, C S Locke, et al.Antimicrobial Agents and Chemotherapy|December 3, 1998
Effect of fluoxetine on pharmacokinetics of ritonavirD Ouellet, A Hsu, J Qian, et al.European Journal of Clinical Pharmacology|January 1, 1997
The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadineW M Awni, J H Cavanaugh, P Leese, et al.Clinical Pharmacokinetics|January 1, 1995
The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteersS L Wong, W M Awni, J H Cavanaugh, et al.Clinical Pharmacology and Therapeutics|March 1, 1995
The effect of zileuton on antipyrine and indocyanine green dispositionJ V St Peter, R A Braeckman, G R Granneman, et al.Clinical Pharmacokinetics|January 1, 1995
The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteersW M Awni, R A Braeckman, J H Cavanaugh, et al.Pageof 4